Biblio
Found 7 results
[ Author
Filters: First Letter Of Last Name is O [Clear All Filters]
“Chemotherapy of advanced ovarian cancer: current status and future directions.”, Semin Oncol, vol. 24, no. 1 Suppl 2, pp. S2-1-S2-9, 1997.
, “ICON3 and chemotherapy for ovarian cancer”, Lancet, vol. 360, pp. 2086-7; author reply 2088, 2002.
, “Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study”, J Clin Oncol, vol. 21, pp. 3194-200, 2003.
, “Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.”, Lancet Oncol, vol. 16, no. 8, p. 936, 2015.
, “A randomized phase III trial comparing weekly parenteral methotrexate and "pulsed" dactinomycin as primary management for low-risk gestational trophoblastic neoplasia. ”, Society Gynecologic Oncologists, 2008.
, “Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary.”, Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S20-5, 2014.
, “Potential impact of combined high- and low-risk human papillomavirus infection on the progression of cervical intraepithelial neoplasia 2”, J Obstet Gynaecol Res, vol. 40, pp. 561-9, 2014.
,